Bayer Archives - Journal for Clinical Studies

Current Edition

Regional News

Bayer leads $80M funding round for Cellino, betting on new cell therapy manufacturing platform

Since it was established in 2017, Cellino Biotech has offered an intriguing approach to stem cell therapy manufacturing, combining biology, laser physics, gene editin...

26 January 2022 Regional News Bayer | cell

Continue Reading →

news

Bayer/Nektar experimental inhaled antibiotic fails in Phase III

Bayer and Nektar Therapeutics’ experimental inhaled antibiotic has failed to hit key targets assessing its effect on survival in patients with Gram-negative pneumonia...

29 November 2017 news antibiotic | Bayer

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Rare Disease Ebook

Decentralised Clinical Trials in The EU

RWS – eBook

It’s All About Stem Cells

Covid-19

Current Edition

Bayer leads $80M funding round for Cellino, betting on new cell therapy manufacturing platform

Bayer/Nektar experimental inhaled antibiotic fails in Phase III

Journal for Clinical Studies